Wednesday, August 24, 2011

Covidien Announces Investor Meeting Agenda


DUBLIN - Wednesday, August 24th 2011 [ME NewsWire]

(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Thursday, September 8, 2011. The event will be held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY. A webcast of the presentations will begin at 2:00 pm ET and the webcast will conclude by 5:00 pm ET.

The program will include presentations by Covidien's President and Chief Executive Officer José (Joe) E. Almeida and Chief Financial Officer Charles J. Dockendorff, as well as Q&A with members of the senior management team. For those investors who are unable to attend the meeting in person, but who would like to ask a question of the management team during the meeting, questions can be emailed to 2011cov@gmail.com.

Agenda

12:00 pm Registration Opens

12:30 pm Product Displays and Senior Management Reception

2:00 pm Program begins

José (Joe) E. Almeida, President and CEO
Q&A with Senior Management Team

4:00 pm Charles J. Dockendorff, Chief Financial Officer

4:30 pm Financial Q&A

5:00 pm Presentations and webcast end

Advanced registration is required and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website: http://survey.covidien.com/survey/375951/1bd6/

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien’s website: http://investor.covidien.com. A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit www.covidien.comto learn more about our business.

Contacts

Covidien

Eric Kraus, 508-261-8305

Senior Vice President

Corporate Communications

eric.kraus@covidien.com



Coleman Lannum, CFA, 508-452-4343

Vice President

Investor Relations

cole.lannum@covidien.com



Bruce Farmer, 508-452-4372

Vice President

Public Relations

bruce.farmer@covidien.com



Todd Carpenter, 508-452-4363

Director

Investor Relations

todd.carpenter@covidien.com

No comments:

Post a Comment